Literature DB >> 9843432

Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.

I Gromova1, H Biersack, S Jensen, O F Nielsen, O Westergaard, A H Andersen.   

Abstract

In mammalian cells, DNA topoisomerase II is the product of two distinct genes encoding the alpha and beta isoforms of the enzyme. Besides homodimeric topoisomerase IIalpha and IIbeta, we have recently shown that alpha/beta heterodimers constitute a third population of topoisomerase II in HeLa cells. We found that topoisomerase II heterodimers are not restricted to HeLa cells but exist in different mammalian cell types, and up to 25% of the total topoisomerase IIbeta population is involved in heterodimer formation. Studies of topoisomerase II phosphorylation in HeLa cells show that heterodimers are phosphorylated in vivo to a significantly lower level compared to homodimeric alpha enzymes, but in contrast to the latter neither heterodimers nor topoisomerase IIbeta homodimers coprecipitate together with a kinase activity that is able to mediate their phosphorylation. However, both enzymes can still be phosphorylated by exogenously added casein kinase II. The differential phosphorylation of topoisomerase II heterodimers suggests an alternative regulation of this topoisomerase II subclass compared to the homodimeric topoisomerase IIalpha counterparts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843432     DOI: 10.1021/bi981391l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  MYC assembles and stimulates topoisomerases 1 and 2 in a "topoisome".

Authors:  Subhendu K Das; Vladislav Kuzin; Donald P Cameron; Suzanne Sanford; Rajiv Kumar Jha; Zuqin Nie; Marta Trullols Rosello; Ronald Holewinski; Thorkell Andresson; Jan Wisniewski; Toyoaki Natsume; David H Price; Brian A Lewis; Fedor Kouzine; David Levens; Laura Baranello
Journal:  Mol Cell       Date:  2021-12-09       Impact factor: 17.970

2.  Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.

Authors:  J J Bower; G F Karaca; Y Zhou; D A Simpson; M Cordeiro-Stone; W K Kaufmann
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

3.  Topoisomerase 2β mutation impairs early B-cell development.

Authors:  Olivier Papapietro; Anita Chandra; Davide Eletto; Sarah Inglott; Vincent Plagnol; James Curtis; Mailis Maes; Ali Alisaac; Adriana S Albuquerque; Eugenie Basseres; Olivier Hermine; Capucine Picard; Alain Fischer; Anne Durandy; Sven Kracker; Siobhan O Burns; Delphine Cuchet-Lourenco; Klaus Okkenhaug; Sergey Nejentsev
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.